Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer-Reference-Cited by-同舟云学术

Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer

Published:2015-12-30 Issue:6 Volume:49 Page:1607-1613
ISSN:1010-7940
Container-title:European Journal of Cardio-Thoracic Surgery
language:en
Short-container-title:Eur J Cardiothorac Surg

Author:

Yang Chi-Fu Jeffrey,Adil Syed M.,Anderson Kevin L.,Meyerhoff Robert Ryan,Turley Ryan S.,Hartwig Matthew G.,Harpole David H.,Tong Betty C.,Onaitis Mark W.,D'Amico Thomas A.,Berry Mark F.

Funder

Medical Scientist Training Program NSRA

NIH

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

http://academic.oup.com/ejcts/article-pdf/49/6/1607/7914965/ezv431.pdf

Reference25 articles.

1. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

2. The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement;Martins;J Natl Compr Canc Netw,2012

3. Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer

4. Outcome of surgery versus radiotherapy after induction treatment in patients with N2 disease: systematic review and meta-analysis of randomised trials

5. Completely resected stage IIIA non–small cell lung cancer: The significance of primary tumor location and N2 station

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma;Nature Communications;2023-05-20

2. Mediastinal restaging with transcervical extended mediastinal lymphadenectomy in patients with locally advanced non-small cell lung cancer treated with pneumonectomy;AME Medical Journal;2022-09

3. Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer;Translational Lung Cancer Research;2021-09

4. Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art;Cancer Communications;2021-03-10

5. Commentary: Minimally Invasive Surgery in N2 Stage IIIA Lung Cancer: Time for Caution Not Time to Throw Caution to the Wind;Seminars in Thoracic and Cardiovascular Surgery;2021